-
Pfizer‘s new anti-cancer drug axitinib declared for new indications in China...
On August 16, the official website of the Center For Drug Evaluation,NMPA announced that Pfizer‘s application for the listing of axitinib tablets for a new indication was accepted,。...
See More
-
Poly Pharm Receives U.S. Marketing Approval for New Specification of B...
Recently, FDA marketing authorization was granted for additional sizes of benzenesulfonium atracurium injection: 10mg/5ml and 200mg/20ml. Previously, Puli Pharma‘s benzenesulfonium atracurium ...
See More
-
Iohexol--drugs for medical imaging diagnosis...
Therefore, research on iohexol impurities pharmaceutical quality control is very critical, most of the current production and quality control of iohexol is based on the European Pharmacopoeia metho...
See More
-
Simelglutide Adds New Indication
Semaglutide is a long-acting glucagon-like peptide-1 receptor agonist (GLP-1RA), which has been approved for the treatment of type 2 diabetes mellitus and obesity in several countries and region...
See More
-
Baricitinib —— the solution to the problem of hair loss....
Jerry Shapiro said in WCD 2023 Oral Presentation. that for patients with a shorter course of alopecia areata, regardless of severity, the proportion of patients who get a clinical response aft...
See More
-
Drug Impurity ——glycoconjugate
Sugar compounds in drug impurity pairs include various types such as monosaccharides, oligosaccharides and polysaccharides. These sugar compounds may be present in different forms in drugs and thei...
See More
-
Tenofovir: full impurity supply
In terms of the human limits of impurities, the International Pharmacopoeia (WHO 11th edition) for tenofovir stipulates the following limits: the area of any peak due to tenofovir monoester (imp...
See More
-
New compound antibiotic - Avibactam
Avibactam is a novel β-lactamase inhibitor used in combination with ceftazidime for the treatment of serious infections caused by drug-resistant gram-negative bacteria. Current research on avibacta...
See More
-
Heat anti-Parkinson’s Disease——Carbidopa and LevodopaCR Tablets the f...
Recently,China Drug Administration (CDA)publicised the SJZ NO.4 Pharmaceutical approval certificate delivery information, CarbidopaandLevodopaCRTablets approved for listing, deemed t...
See More
-
Statin "Top Stream" is Coming - Rosuvastatin Impurities Supply...
The impurity study in its synthesis and quality control is an important part to ensure the safety and efficacy of the drug. Domestic and foreign pharmacopoeias have recorded the impurities of Rosuv...
See More
-
Beda Pharmaceuticals‘ CFT8919 Capsule Clinical Trial Application Acce...
On 9 July, Beda Pharmaceuticals and C4 Therapeutics, Inc. (C4T) received the Notice of Acceptance (Acceptance No. CXHL2400676 and CXHL2400677) from the State Drug Administratio...
See More
-
New Alzheimer‘s drug gets FDA approval for marketing...
The U.S. Food and Drug Administration (FDA) approved Kisunla™ (donanemab-azbt, 350 mg/20 mL once-monthly injection for IV infusion), Eli Lilly and Company‘s Alzheimer‘s treatment f...
See More
-
Finerenon,a new diabetic nephropathy drug...
Finerenone has been on the market for a short period of time, and with the accumulation of clinical experience and research evidence, it is expected to bring more benefits to diabetic nephropathy pat...
See More
-
Technical Guidelines for Clinical Trials of Drugs for Chronic Hepatitis D...
Technical Guidelines for Clinical Trials of Drugs for Chronic Hepatitis D Virus Infection
See More
-
Omadacycline: impurity studies of a new tetracycline antibiotic...
Omadacycline advantageous pathogens wide, can be used for a variety of identified pathogens caused by infections, in addition to the pharmacological mechanism of the study, in the quality control, th...
See More
-
Impurity study of marbofloxacin, the "miracle drug" against influenza...
The main source of impurities in Marbovir is the synthesis side reaction. In the study "Simultaneous determination of three stereoisomers in Marbovir API by reversed-phase high performance liq...
See More
-
Difference between Ornidazole, Levonidazole, and Levonidazole Phosphate Di...
Ornidazole, Levonidazole, are both approved for the treatment of anaerobic infections and protozoal infections. The structure of Ornidazole contains a chiral carbon atom with a hydroxyl group, whi...
See More
-
Supply of drug impurities: Diagnostic reagents - iopromide...
Iopromide, chemically known as N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxy)acetamido]-N-methyl-1,3-benzenedicarboxamide, is a chemically active ingredient (API) for non-ionic iodin...
See More
-
‘Parkinson‘s’ drug development - pramipexole impurities...
The sources of impurities in pramipexole can be categorised into several: One is impurities from the synthesis process. For example, the pramipexole hydrochloride degradation impurity BI-IO460B...
See More
-
Minocycline impurity
During partial minocycline synthesis, due to the presence of poorly oriented minocycline (minocycline EP impurity A) in the raw material itself and the increase in its content by both photo-destru...
See More